Taken all together, these different signaling paradigms involved with EMT in ovarian cancer suggest that growth factor receptor glycosylation modification involving the receptor-signaling platform of a Neu1-MMP9 crosstalk may in fact be the invisible link connecting the Snail-MMP9 signaling axis as depicted in Figure 1. This evidence concerns the gene NEU1 and ovarian cancer.